Literature DB >> 7691144

Autonomous production of granulocyte-colony stimulating factor in tumour xenografts associated with leukocytosis.

Y Katoh1, M Nakamura, Y Ohnishi, K Shimamura, Y Ueyama, N Tamaoki.   

Abstract

Leukocytosis sometimes accompanies malignant neoplasms in the absence of infection. It is thought that the production of colony-stimulating factor by neoplasms is the most potent cause of tumour-induced leukocytosis; several mechanisms have been suggested to explain this. We examined 155 human tumour xenografts established in nude mice, and found that 17 of the xenografts induced remarkable leukocytosis (> 15,000 microliters-1) in nude rats. We examined granulocyte colony-stimulating factor (G-CSF) production by the xenografts to study the mechanisms underlying this tumour-induced leukocytosis. Ten of the 17 xenografted human tumours appeared to express the G-CSF gene. Serum G-CSF increased, to concentrations of 179-37,218 pg ml-1, in host animals transplanted with the ten xenografts expressing the G-CSF gene transcripts. The biological activity of serum G-CSF also increased, to concentrations of 206-9,074 pg ml-1, in the host animals transplanted with the ten xenografts. Immunohistochemical analysis demonstrated G-CSF production at the cellular level in three of the ten xenografts. These results suggested that the production of G-CSF is a common event in human tumour xenografts associated with leukocytosis, but that factors other than G-CSF are also likely to be involved. Leukocytosis induced by neoplasms seems to be a heterogeneous and complex disorder.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691144      PMCID: PMC1968588          DOI: 10.1038/bjc.1993.416

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Expression of colony-stimulating factor genes by normal human mesothelial cells and human malignant mesothelioma cells lines in vitro.

Authors:  G D Demetri; B W Zenzie; J G Rheinwald; J D Griffin
Journal:  Blood       Date:  1989-08-15       Impact factor: 22.113

2.  A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders.

Authors:  N Shirafuji; S Asano; S Matsuda; K Watari; F Takaku; S Nagata
Journal:  Exp Hematol       Date:  1989-02       Impact factor: 3.084

3.  Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells.

Authors:  W E Berdel; S Danhauser-Riedl; G Steinhauser; E F Winton
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

4.  Quantitative enzyme immunoassay for human granulocyte colony stimulating factor (G-CSF).

Authors:  H Motojima; T Kobayashi; M Shimane; S Kamachi; M Fukushima
Journal:  J Immunol Methods       Date:  1989-03-31       Impact factor: 2.303

5.  Interleukin 1 and poly(rI).poly(rC) induce production of granulocyte CSF, macrophage CSF, and granulocyte-macrophage CSF by human endothelial cells.

Authors:  W E Fibbe; M R Daha; P S Hiemstra; N Duinkerken; E Lurvink; P Ralph; B W Altrock; K Kaushansky; R Willemze; J H Falkenburg
Journal:  Exp Hematol       Date:  1989-03       Impact factor: 3.084

6.  Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines.

Authors:  B R Avalos; J C Gasson; C Hedvat; S G Quan; G C Baldwin; R H Weisbart; R E Williams; D W Golde; J F DiPersio
Journal:  Blood       Date:  1990-02-15       Impact factor: 22.113

7.  Establishment of specific monoclonal antibodies against recombinant human granulocyte colony-stimulating factor (hG-CSF) and their application for immunoperoxidase staining of paraffin-embedded sections.

Authors:  K Shimamura; J Fujimoto; J Hata; A Akatsuka; Y Ueyama; T Watanabe; N Tamaoki
Journal:  J Histochem Cytochem       Date:  1990-02       Impact factor: 2.479

8.  Mechanisms of tumor-induced neutrophilia: constitutive production of colony-stimulating factors and their synergistic actions.

Authors:  M Y Lee; K Kaushansky; S A Judkins; J L Lottsfeldt; A Waheed; R K Shadduck
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

9.  Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF.

Authors:  I McNiece; R Andrews; M Stewart; S Clark; T Boone; P Quesenberry
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

10.  Electron microscopic identification of the intracellular secretion pathway of human G-CSF in a human tumor cell line: a comparative study with a Chinese hamster ovary cell line (IA1-7) transfected with human G-CSF cDNA.

Authors:  A Akatsuka; K Shimamura; Y Katoh; S Takekoshi; M Nakamura; H Nomura; M Hasegawa; Y Ueyama; N Tamaoki
Journal:  Exp Hematol       Date:  1991-09       Impact factor: 3.084

View more
  9 in total

Review 1.  Cancer-associated myeloproliferation: old association, new therapeutic target.

Authors:  Ryan A Wilcox
Journal:  Mayo Clin Proc       Date:  2010-07       Impact factor: 7.616

2.  Genomic analysis of the thymine-DNA glycosylase (TDG) gene on 12q22-q24.1 in human pancreatic ductal adenocarcinoma.

Authors:  T Yatsuoka; T Furukawa; T Abe; T Yokoyama; M Sunamura; M Kobari; S Matsuno; A Horii
Journal:  Int J Pancreatol       Date:  1999-04

3.  Murine Mammary Carcinoma Induces Chronic Systemic Inflammation and Immunosuppression in BALB/c Mice.

Authors:  Dasha Fuentes; Alejandro Cabezas-Cruz; Circe Mesa; Tania Carmenate; Darel Martínez; Anet Valdés-Zayas; Enrique Montero; Rolando Pérez
Journal:  J Breast Cancer       Date:  2022-04-26       Impact factor: 2.922

4.  Rapid progression of a granulocyte colony-stimulating factor-producing liver tumor metastasized from esophagogastric junction cancer: A case report and literature review.

Authors:  Sojun Hoshimoto; Nobuo Hoshi; Iwao Ozawa; Moriaki Tomikawa; Hirofumi Shirakawa; Takeshi Fujita; Saho Wakamatsu; Sayuri Hoshi; Kaoru Hirabayashi; Shoichi Hishinuma; Yoshiro Ogata
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

5.  [Long-term changes in peripheral blood leukocyte and lymphocyte populations in ENT-carcinoma patients. A flow cytometric study in 346 ENT-carcinoma patients and 31 healthy controls].

Authors:  J Ostwald; S Dommerich; U Schulz; B Kramp
Journal:  HNO       Date:  2004-08       Impact factor: 1.284

6.  Comparative study of inhibitory effects by murine interferon gamma and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK).

Authors:  M Tohkin; S Kakudo; H Kasai; H Arita
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

7.  Leukemoid reaction in a patient with adenocarcinoma of the lung: a case report.

Authors:  Hendrik Riesenberg; Frauke Müller; Martin Görner
Journal:  J Med Case Rep       Date:  2012-07-19

8.  Favorable response to pembrolizumab in granulocyte colony-stimulating factor-producing upper urinary tract urothelial carcinoma.

Authors:  Hiroki Takeda; Ryuji Matsumoto; Emi Takakuwa; Kanta Hori; Takuya Moriguchi; Shuhei Yamada; Hiroshi Kikuchi; Takahiro Osawa; Takashige Abe; Nobuo Shinohara
Journal:  IJU Case Rep       Date:  2021-12-17

9.  Prognostic Value of White Blood Cells Detected for the First Time After Adjuvant Chemotherapy in Primary Operable Non-Small Cell Lung Cancer.

Authors:  Ligang Hao; Junjie Zhang; Yonghui Di; Zhenbo Tan
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.